Expresses the sense of the Senate that the United States should make a substantial new investment this year in bioterrorism preparedness and response, including: (1) improving State and local preparedness capabilities, hospital response capabilities, disaster response medical systems, and the National Pharmaceutical Stockpile program; (2) upgrading the capabilities of the Centers for Disease Control and Prevention (CDC); (3) targeting research for therapeutics and vaccines for bioterrorist agents and food safety activities; and (4) increasing international cooperation in securing biological agents, increasing surveillance, and retraining biological warfare specialists.
Actions
Oct 11, 2001
Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S10653-10654)
Oct 11, 2001
Sponsor introductory remarks on measure. (CR S10654-10655)